Jad M. Abdelsattar, M.D., MD

Dr. Jad M. Abdelsattar is an SSO-accredited, fellowship-trained breast surgical oncologist, oncoplastic surgeon, educator, and clinical AI researcher focused on applying emerging technologies to cancer care. He completed fellowship training in Breast Surgical Oncology and Oncoplastic Surgery at the University of Southern California–Hoag Memorial Hospital Presbyterian, following surgical training and postdoctoral research at West Virginia University Medicine and the Mayo Clinic. Board-certified by the American Board of Surgery, he will soon begin graduate studies at the University of Oxford, concentrating on leadership, innovation, and quality initiatives. His planned thesis will examine the responsible adoption of artificial intelligence to support decision-making in healthcare systems.
Dr. Abdelsattar integrates clinical practice with innovation, education, and health system improvement. His research covers breast cancer surgery, computational pathology, precision oncology, surgical education, simulation, diversity and inclusion, and clinical artificial intelligence. He has authored over 50 scientific publications and book chapters, including Mayo Clinic General Surgery, published by Oxford University Press in 2020. He has led research on the use of AI to enhance cancer diagnosis, prognostication, and workflow efficiency.
As a surgical resident and fellow, he was appointed to several impressive leadership roles, including American College of Surgeons Resident Chapter Representative, serving all surgery residency programs in West Virginia, and positions with the American College of Surgeons Division of Diversity and Inclusion and the Association of Program Directors in Surgery DEI committee. Dr. Abdelsattar currently serves on the American Society of Breast Surgeons’ Inaugural Artificial Intelligence Task Force and Patient Safety & Quality Committee, as well as the Society of Surgical Oncology’s SPHERE Committee. His leadership extends beyond academic medicine through collaborations with healthcare technology and AI companies, professional societies, and multidisciplinary teams to develop safer, more effective, and equitable models of care within breast cancer service lines.
As a speaker, Dr. Abdelsattar brings a unique perspective shaped by frontline surgical practice, health technology innovation, and the implementation science of artificial intelligence. His presentations focus on the future of cancer care, clinical AI adoption, physician trust in technology, and the human factors that determine whether innovation and AI succeed at scale.